| 14.03 Data as of May 23 | +0.28 / +2.04%Today’s Change | 9.13 Today|||52-Week Range 16.29 | +41.15% Year-to-Date |
| Encouraging News for Peregrine Pharma - Analyst Blog May 23 / Zacks.com | SGEN's Adcetris under FDA Review - Analyst Blog May 16 / Zacks.com |
| Biogen Submits Plegridy BLA - Analyst Blog May 23 / Zacks.com | Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog May 15 / Zacks.com |
| XenoPort Candidate Disappoints - Analyst Blog May 21 / Zacks.com | Amgen to Set Up JV in China - Analyst Blog May 14 / Zacks.com |
| July Options Now Available For Anika Therapeutics (ANIK) May 20 / TheStreet.com | Disappointing 1Q Earnings for IART - Analyst Blog May 10 / Zacks.com |
| Biogen's Hemophilia BLA Accepted - Analyst Blog May 20 / Zacks.com |